Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Established Markets: $40,555M in FY2025, up 8.5% from a year earlier.
Latest, FY2025
40,555
Period ended Dec 31, 2025
Change on a year earlier
+8.5%
37,371 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Of which in established markets | 40 555 | 37 371 | 9 | 7 | 74 | 74”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Established Markets ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40,555 | +8.5% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 37,371 | +10.8% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 33,725 | +7.5% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 31,386 | -2.5% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 32,183 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up established Markets
Cite this data
StockData. (2026). Novartis Established Markets ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-established-markets
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.